TETI, Giuseppe
 Distribuzione geografica
Continente #
EU - Europa 12.226
NA - Nord America 10.761
AS - Asia 5.748
SA - Sud America 1.926
Continente sconosciuto - Info sul continente non disponibili 190
AF - Africa 161
OC - Oceania 13
Totale 31.025
Nazione #
US - Stati Uniti d'America 10.564
RU - Federazione Russa 6.093
SG - Singapore 2.308
CN - Cina 1.976
BR - Brasile 1.687
IE - Irlanda 1.414
SE - Svezia 1.256
IT - Italia 713
DE - Germania 661
HK - Hong Kong 553
UA - Ucraina 553
FR - Francia 469
FI - Finlandia 324
VN - Vietnam 272
GB - Regno Unito 257
PL - Polonia 221
IN - India 130
BD - Bangladesh 103
AR - Argentina 88
CA - Canada 74
CZ - Repubblica Ceca 54
IQ - Iraq 54
MX - Messico 51
TR - Turchia 50
BE - Belgio 49
ZA - Sudafrica 46
EC - Ecuador 39
MA - Marocco 36
PK - Pakistan 36
CO - Colombia 32
JP - Giappone 32
UZ - Uzbekistan 31
ES - Italia 28
NL - Olanda 27
VE - Venezuela 24
AT - Austria 23
ID - Indonesia 23
CL - Cile 20
KE - Kenya 19
AE - Emirati Arabi Uniti 17
SA - Arabia Saudita 17
TN - Tunisia 17
PH - Filippine 16
CR - Costa Rica 14
JO - Giordania 14
AZ - Azerbaigian 12
EG - Egitto 12
UY - Uruguay 12
DO - Repubblica Dominicana 11
DZ - Algeria 11
JM - Giamaica 10
BG - Bulgaria 9
HN - Honduras 9
IR - Iran 9
LT - Lituania 9
NP - Nepal 9
PY - Paraguay 9
CH - Svizzera 8
IL - Israele 8
KG - Kirghizistan 8
KZ - Kazakistan 8
PE - Perù 8
PS - Palestinian Territory 8
PT - Portogallo 8
AL - Albania 7
AU - Australia 7
MY - Malesia 7
RO - Romania 7
EU - Europa 6
GT - Guatemala 6
LV - Lettonia 6
OM - Oman 6
PA - Panama 6
AM - Armenia 5
SN - Senegal 5
AO - Angola 4
BN - Brunei Darussalam 4
BO - Bolivia 4
LB - Libano 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BH - Bahrain 3
CI - Costa d'Avorio 3
DK - Danimarca 3
GR - Grecia 3
GY - Guiana 3
HR - Croazia 3
KH - Cambogia 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
AG - Antigua e Barbuda 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
BZ - Belize 2
CY - Cipro 2
EE - Estonia 2
ET - Etiopia 2
Totale 30.806
Città #
Moscow 1.856
Dublin 1.412
Singapore 1.258
Ashburn 1.253
Dallas 1.221
Chandler 1.128
Jacksonville 1.122
Nyköping 687
San Jose 563
Hong Kong 551
Beijing 534
Shenzhen 469
Council Bluffs 381
Messina 288
The Dalles 283
Dearborn 249
Los Angeles 248
Princeton 243
Cambridge 235
Medford 235
Lauterbourg 221
Warsaw 215
Boardman 213
Des Moines 196
Ann Arbor 188
Buffalo 146
New York 124
Munich 115
São Paulo 115
Ho Chi Minh City 82
Woodbridge 80
Bremen 70
Tianjin 69
Hanoi 61
Shenyang 60
Wilmington 58
Jinan 55
Orem 53
Santa Clara 52
Belo Horizonte 50
Brussels 48
Brno 47
San Mateo 47
Guangzhou 45
Helsinki 43
Chennai 41
Redondo Beach 39
Turku 39
Columbus 37
Frankfurt am Main 35
Rio de Janeiro 35
Nanjing 34
Milan 32
Pune 32
Brasília 30
Lancaster 30
Nuremberg 30
Haikou 29
Tashkent 29
Tokyo 29
Rome 27
Seattle 27
Brooklyn 26
Hebei 26
Shanghai 26
Houston 25
Ningbo 25
Johannesburg 24
Zhengzhou 24
Dong Ket 23
Baghdad 22
Curitiba 22
London 22
Montreal 22
Norwalk 22
Düsseldorf 21
Stockholm 21
Denver 20
Dhaka 20
Phoenix 20
Porto Alegre 20
Mumbai 19
Amsterdam 18
Ribeirão Preto 18
Taiyuan 18
Goiânia 17
Hangzhou 17
Poplar 17
Campinas 16
Chicago 16
Guayaquil 16
Taizhou 16
Washington 16
Catania 15
Boston 14
Nairobi 14
Vienna 14
Amman 13
Guarulhos 13
Haiphong 13
Totale 17.955
Nome #
Immunogenic Properties of Streptococcus agalactiae FbsA Fragments. 621
ATTIVAZIONE DI NLRP3 IMFLAMMASOMA NEL CORSO DELLE INFEZIONI SOSTENUTE DAGLI STREPTOCOCCHI DI GRUPPO B 277
Functional characterization of a monoclonal antibody epitope using a lambda phage display-deep sequencing platform 248
Neutrophils Directly Recognize Group B Streptococci and Contribute to Interleukin-1β Production during Infection. 240
Antiidiotypic DNA vaccination induces serum bactericidal activity and protection against group B meningococci 238
Analysis of the secretome of the group B Streptococcus 220
Epitope mapping of a monoclonal antibody directed against neisserial heparin binding antigen using next generation sequencing of antigen-specific libraries 219
Phage display revisited: Epitope mapping of a monoclonal antibody directed against Neisseria meningitidis adhesin A using the PROFILER technology 215
The plasminogen binding protein PbsP is required for brain invasion by hypervirulent CC17 Group B streptococci 214
Anti-idiotypic B5 single chain variable fragment [synthetic construct]. 207
A new surface protein of Streptococcus suis identified by proteomics 207
Analysis of the Streptococcus agalactiae exoproteome. 207
A surface protein of Streptococcus suis serotype 2 identified by proteomics protects mice against infection 205
Activation of the NLRP3 inflammasome by group B streptococci. 204
Anti-idiotypic G1 single chain variable fragment [synthetic construct]. 199
Antibody killing of Candida albicans after immunization with peptides mimicking a killer toxin receptor 197
Essential role of interleukin-1 signaling in host defenses against group B streptococcus 196
CXCL1/2 chemokines are newly synthesized by neutrophils and released at high levels after recognition of live Group B Streptococcus by means of endosomal Toll-like receptors 194
Approccio proteomico per l’analisi comparativa del secretoma di coltura di S. agalactiae, ceppo Nem316 193
Caratterizzazione molecolare di glicoproteine criptococciche capaci di indurre risposte umorali. 190
Characterization of two novel Cryptococcal mannoproteins recognized by immune sera 189
Immunoprotective activities of a Streptococcus suis pilus subunit in murine models of infection. 189
beta(2) integrins are involved in cytokine responses to whole Gram-positive bacteria 187
Bacteroides fragilis-derived lipopolysaccharide produces cell activation and lethal toxicity via toll-like receptor 4 185
Anti-idiotypic vaccination against group B streptococci 185
Neutrophils Enhance Their Own Influx to Sites of Bacterial Infection via Endosomal TLR-Dependent Cxcl2 Production 183
Protective Activity of Streptococcus pneumoniae Spr1875 Protein Fragments Identified Using a Phage Displayed Genomic Library. 178
NEUTROPHILS PRODUCE HIGH LEVELS OF CHEMOKINES (CXCL1/2) AFTER SENSING GROUP B STREPTOCOCCUS THROUGH ENDOSOMAL TLRS 177
The Streptococcus agalactiae cell wall-anchored protein PbsP mediates adhesion to and invasion of epithelial cells by exploiting the host vitronectin/αvintegrin axis 177
Bacteroides fragilis lipopolysaccharide activates cells via CD14/MD2/TLR4 176
Peptide mimics of the group B meningococcal capsule induce bactericidal and protective antibodies after immunization 176
“Antibody killing of Candida albicans after immunization with peptides mimicking a killer toxin receptor” 175
Neonatal mouse immunity against group B streptococcal infection by maternal vaccination with recombinant anti-idiotypes 175
Costruzione e screening di librerie “lambda display” da genoma completo di streptococchi patogeni per l’identificazione di prodotti genici che interagiscono con i tessuti dell’ospite. 174
Age-related sensitivity of neonatal mice to toxicity induced by heat-killed group B streptococci. 174
Immunoprotective activities of a Streptococcus suis pilus subunit in murine models of infection 173
Attivazione dell'inflammasoma da parte di S.pneumoniae 172
Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells 172
The IL-1b/CXCL1/2/neutrophil axis mediates host protection against group B streptococcal infection 170
MyD88 and TLR2, but not TLR4, are required for host defense against Cryptococcus neoformans 169
Plasminogen- and Fibronectin–Binding Protein B Is Involved in the Adherence of Streptococcus pneumoniae to Human Epithelial Cells. 168
NEUTROPHILS ARE MAINLY RESPONSIBLE FOR IL-1Β PRODUCTION DURING GROUP B STREPTOCOCCUS INFECTION 168
Role of gamma interferon in a neonatal mouse model of group B streptococcal disease 167
PbsP, a cell wall-anchored protein that binds plasminogen to promote hematogenous dissemination of Group B Streptococcus 167
CELL ACTIVATION INDUCED BY LIPOTEICHOIC ACID AND POLYSACCHARAIDES FRM STREPTOCOCCI. 166
Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease 166
Identificazione mediante “Phage Display” diframmenti biologicamente attivi della fibrinogenbinding protein A (FbsA) di Streptococcus agalactiae. 165
Protective activity of a protein fragment identified by the screening of a Streptococcus pneumoniae phage-displayed genomic library 165
Yeast Killer Toxin-Like Candidacidal Ab6 Antibodies Elicited through the Manipulation of the Idiotypic Cascade 165
Neutrophils discriminate live from dead bacteria by integrating signals initiated by Fprs and TLRs 165
Immunogenic mimics of Brucella lipopolysaccharide epitopes 164
Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria 164
A meeting of mimics. 163
AGE-RELATED MORTALITY AND ADHERENT SPLENIC CELL MEDIATOR PRODUCTION TO ENDOTOXIN IN THE RAT 162
La proteina FbsA di Streptococcus agalactiae è unimportante fattore di virulenza 161
Rapid Profiling of the Antigen Regions Recognized by Serum Antibodies Using Massively Parallel Sequencing of Antigen- Specific Libraries 161
Isolation of bacterial RNA from infected host tissues: application for transcriptomic studies of group B streptococci 161
Neonatal hypersusceptibility to endotoxin correlates with increased tumor necrosis factor production in mice 160
Ruolo dell'interluchina 18 nelle infezioni da streptococco di gruppo B. 159
Adherence of group B streptococci to adult and neonatal epithelial cells mediated by lipoteichoic acid. 159
ANTI-LIPOTEICHOIC ACID ANTIBODIES ENHANCE RELEASE OF CYTOKINES BY MONOCYTES SENSITIZED WITH LIPOTEICHOIC ACID 156
Plasminogen- and fibronectin-binding protein B is involved in the adherence of Streptococcus pneumoniae to human epithelial cells 155
Proceedings of the second Centro 3R Annual Meeting | September 30th - October 1st of Biomedical Science and Engineering. Vol. 4 No. s1 (2021) 155
Constitutive activation of two-component systems reveals regulatory network interactions in Streptococcus agalactiae 154
Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components 154
Evaluation of a rapid method to exclude the presence of certain enteric pathogens in stool specimens. 154
The Phagocyte, Metchnikoff, and the Foundation of Immunology 153
Effects of taxol on TNF-alpha and IL-6 production by human peripheral blood cells. 152
Virus ed infezioni alimentari: il caso dell’epatite A 150
Role of TLR13 in innate immune recognition of group B streptococci 149
Uso del “phage display”per caratterizzare ilrepertorio anticorpale indotto da vaccinazione. 148
Recognition of Neisseria meningitidis by the Long Pentraxin PTX3 and Its Role as an Endogenous Adjuvant 145
BETA-LACTAM ANTIBIOTICS (AZTREONAM, AMPICILLIN, CEFAZOLIN AND CEFTAZIDIME) IN THE CONTROL AND ERADICATION OF SALMONELLA- TYPHIMURIUM IN NATURALLY RESISTANT AND SUSCEPTIBLE MICE 145
Immunoprotective activity of a Streptococcus pneumoniae protein identified by phage display. 145
Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13 144
Combating antibiotic resistance in S. pneumoniae infections: identification of pneumolysin binding peptides 144
Effects of anti-cytokine treatments in neonatal sepsis models 144
VACCINE FORMULATIONS COMPRISING ANTIIDIOTYPIC ANTIBODIES WHICH IMMUNOLOGICALLY MIMIC GROUP B STREPTOCOCCAL CARBOHYDRATES 143
Identification and cloning of a cryptococcal deacetylase that produces protective immune responses 143
Cross reattività di una lipoproteina di Neisseriameningitidis con la proteina legante il fattore H (fHbp) 143
Plasminogen binding and immunoprotective properties of the Mk-rich domain of PbsP, a cell wall protein from Streptococcus agalactiae 143
Role of host's immune response in infections caused by Streptococcus pneumoniae 143
[Genetic techniques for the production of influenza vaccines (author's transl)]. 142
BENEFICIAL-EFFECTS OF INTERLEUKIN-6 IN NEONATAL MOUSE MODELS OF GROUP-B STREPTOCOCCAL DISEASE 141
[Echocardiographic size of the left atrium and pulmonary "capillary" pressure in different cardiopathies]. 140
Identification of fibrinogen binding protein fragments using genomic phage display libraries of Group B Streptococcus 139
Interleukin-18 is an essential element in host resistance to experimental group B streptococcal disease in neonates 138
Immunità protettiva indotta da una glutamina sintetasi di Cryptococcus neoformans 137
Plasminogen- and fibronectin–binding protein B is involved in the adherence of Streptococcus pneumoniae to human epithelial cell 137
Selection of Neisseria meningitidis group B antigenic epitopes using lambda libraries. 137
Induction of bactericidal antibodies by DNA Immunization with peptide mimics of the meningococcal capsule 136
Pro-interleukin-1 beta processing in response to streptococci is totally caspase-1 dependent in vitro, but not in vivo. 136
Vaccinazione anti-idiotipica a DNA per l'induzione di anticorpi diretti contro il polissacaride di batteri capsulati. 135
Compositional analysis of the major capsular polysaccharides of Cryptococcus neoformans by high-performance anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD) 135
Interleukin-10 protects neonatal mice from lethal group B streptococcal infection 135
[Refractory junctional tachycardia controlled by radio-frequency programmed stimulation in association with amiodarone treatment]. 135
Comparison of six systems for the identification of Enterobacteriaceae. 135
The dual role of innate immunity during influenza 135
Caratterizzazione immunologica di nuovi antigeni proteici di Streptococcus pneumoniae selezionati mediante “phage-display 132
[Pseudoischemic unstable T wave with familial incidence]. 130
Totale 17.240
Categoria #
all - tutte 100.030
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.030


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.582 0 259 16 34 37 11 114 76 17 192 288 538
2022/20234.266 341 348 178 388 412 408 58 243 1.712 19 115 44
2023/20241.456 86 159 526 86 105 212 7 58 2 33 16 166
2024/20254.594 79 53 81 289 140 161 89 1.123 1.191 258 367 763
2025/202613.473 550 885 1.098 717 1.070 3.202 1.622 1.646 1.709 493 292 189
2026/2027552 205 347 0 0 0 0 0 0 0 0 0 0
Totale 31.025